In:
Arteriosclerosis, Thrombosis, and Vascular Biology, Ovid Technologies (Wolters Kluwer Health), Vol. 24, No. 7 ( 2004-07), p. 1272-1277
Abstract:
Statins reduce risk by only 30%, and a direct measurement of change in atherosclerosis burden may provide a clue to the persistent risk measured in subjects at risk. On sequential computed tomography scans, the progression of coronary calcification was significantly greater in patients who had an event compared with event-free subjects despite similar low-density lipoprotein control.
Type of Medium:
Online Resource
ISSN:
1079-5642
,
1524-4636
DOI:
10.1161/01.ATV.0000127024.40516.ef
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2004
detail.hit.zdb_id:
1494427-3
Permalink